이 에피소드에 관해
How do you accelerate innovation without compromising ethics?
In this episode of the Notable Men Podcast, host Laura Ezzell sits down with healthcare executive, entrepreneur, investor, and pharmaceutical industry leader William Soliman, PhD, BCMAS, to explore the future of healthcare, artificial intelligence, and the responsibility leaders have to build trust while advancing innovation.
William is the Founder and CEO of the Accreditation Council for Medical Affairs (ACMA), the organization responsible for accrediting, certifying, and training pharmaceutical professionals around the world. He is also the Founder and Chief Investment Officer of White Manna Capital Partners, a healthcare-focused investment firm specializing in biotechnology, obesity medicine, women's health, and emerging healthcare innovation.
Drawing from decades of leadership experience, William shares how one defining ethical moment early in his career shaped his mission to improve industry standards and ensure patients remain at the center of healthcare innovation.
In this conversation, William shares:
▪ Why ethics should always come before profits
▪ The leadership lessons William learned from the Vioxx controversy
▪ How artificial intelligence is transforming drug discovery
▪ Why AI will never replace human judgment in healthcare
▪ The future of obesity medicine and GLP-1 therapies
▪ Why women's health represents one of healthcare's biggest opportunities
▪ What investors look for beyond industry hype
▪ How healthcare companies build trust with physicians and patients
▪ Why transparency creates long-term success
▪ The importance of specialized expertise and personal branding
▪ What separates great healthcare leaders from everyone else
▪ Why leaving an industry better than you found it is the ultimate measure of success
CONNECT WITH WILLIAM SOLIMAN
YouTube:https://www.youtube.com/@willsoliman
Instagram:https://www.instagram.com/will_soliman/
TikTok:https://www.tiktok.com/@willsoliman
LinkedIn:https://www.linkedin.com/in/drwilliamsoliman/
